Wyeth’s fen/phen settlement Redux
Executive Summary
The firm announces May 24 that the so-called "Seventh Amendment" of the Redux settlement receives final judicial approval. The Seventh Amendment sets aside $1.275 bil. to fund less serious cases (1"The Pink Sheet" Feb. 7, 2005, In Brief). Wyeth has reserved $21 bil. for fen/phen claims and litigation, and has paid out an estimated $15.75 bil...
You may also be interested in...
Wyeth diet drug litigation
Wyeth increases Redux litigation reserve by $4.5 bil. ($2.6 bil. net of tax), bringing total fen/phen-related charges to $21.1 bil. Wyeth has paid $13.9 bil. in claims, leaving a balance of $7.2 bil. in reserve, as of Dec. 31. The charge assumes the so-called "Seventh Amendment" settlement will be accepted, although it still awaits final court approval. The Seventh Amendment would set aside $1.275 bil. to fund less serious cases (1"The Pink Sheet" Aug. 16, 2004, In Brief)...
Pink Sheet Podcast: Woodcock To Be Acting US FDA Chief, Key Staff Depart, Political Donations Shift
Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.
Liquid Biopsy Company Delfi Diagnostics Raised $100M For New Class of Early Cancer Detection Test
Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: